Missed GME or NVDA? Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
ACAB Stock Forecast 2025-2026
$0.33
Current Price
$46.40M
Market Cap
Buy 0
Hold 0
Sell 0
Wall St Analyst Ratings
Distance to ACAB Price Targets
N/A
To High Target of $N/A
N/A
To Median Target of $N/A
N/A
To Low Target of $N/A
ACAB Price Momentum
+43.5%
1 Week Change
-21.4%
1 Month Change
-96.9%
1 Year Change
-79.0%
Year-to-Date Change
-97.5%
From 52W High of $13.00
+43.5%
From 52W Low of $0.23
📉 MARKET SELLOFF ALERT
10 Quality Stocks Worth Considering Now
Researching Atlantic Coastal II (ACAB) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on ACAB and similar high-potential opportunities.
Latest ACAB Stock Price Targets & Analyst Predictions
ACAB has shown a year-to-date change of -79.0% and a 1-year change of -96.9%, reflecting downward momentum over the past year. Comprehensive analyst forecasts are currently unavailable for ACAB. Please refer to the price chart above for recent performance and trends.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
ACAB Analyst Ratings
0
Buy
0
Hold
0
Sell
ACAB Price Target Range
Low
N/A
Average
N/A
High
N/A
Current: $0.33
Latest ACAB Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for ACAB.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|
Abpro Holdings Inc. (ACAB) Competitors
The following stocks are similar to Atlantic Coastal II based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
ACAB
Atlantic Coastal II
mkt cap
46.40M
Abpro Holdings Inc. (ACAB) Financial Data
Abpro Holdings Inc. has a market capitalization of $46.40M with a P/E ratio of 78.7x. The company generates $0 in trailing twelve-month revenue with a 0.0% profit margin.
Revenue growth is N/A quarter-over-quarter, while maintaining an operating margin of 0.0% and return on equity of -33.1%.
Valuation Metrics
Market Cap
$46.40M
Enterprise Value
$49.27M
P/E Ratio
78.7x
PEG Ratio
0.0x
Price/Sales
0.0x
Growth & Margins
Revenue Growth (YoY)
N/A
Gross Margin
N/A
Operating Margin
0.0%
Net Margin
0.0%
EPS Growth
N/A
Financial Health
Cash/Price Ratio
+8.8%
Current Ratio
0.0x
Debt/Equity
-0.2x
ROE
-33.1%
ROA
-6.1%
💰 DON'T MISS THIS OPPORTUNITY
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
Abpro Holdings Inc. (ACAB) Business Model
About Abpro Holdings Inc.
What They Do
Biotechnology company focused on antibody discovery.
Business Model
Abpro Holdings Inc. generates revenue by leveraging its proprietary antibody discovery platform to develop advanced therapies, particularly in oncology and ophthalmology. The company partners with other organizations to enhance research and development efforts, thus contributing to the biopharmaceutical industry.
Additional Information
Abpro is involved in creating high-affinity antibodies for novel treatments and diagnostic solutions, playing a significant role in precision medicine and global biopharmaceutical development. Its strategic collaborations and innovative approaches are aimed at addressing complex health challenges.
Company Information
Sector
Financial Services
Industry
Shell Companies
Employees
0
CEO
Mr. Shahraab Ahmad
Country
United States
IPO Year
2022
Website
atlantic-coastal.comAbpro Holdings Inc. (ACAB) Latest News & Analysis
Latest News
Quick Summary
Monteverde & Associates is investigating Atlantic Coastal Acquisition Corp. II (Nasdaq: ACAB) regarding its merger with Abpro Merger Sub Corp., converting Abpro shares into Atlantic Coastal shares at 2.06:1.
Why It Matters
The investigation into Atlantic Coastal's merger could impact stock valuations and shareholder returns, affecting investment decisions and market sentiment around ACAB.
Source: PRNewsWire
Market Sentiment:
Neutral
Quick Summary
Atlantic Coastal Acquisition Corp. II (NASDAQ: ACAB) received a notice from Nasdaq for not filing its Q1 2024 report, indicating non-compliance with listing requirements. No immediate effect on listing.
Why It Matters
Atlantic Coastal Acquisition Corp. II's non-compliance with Nasdaq's listing requirements raises concerns about its financial reporting and governance, potentially affecting investor confidence and stock performance.
Source: PRNewsWire
Market Sentiment:
Neutral
Quick Summary
Atlantic Coastal Acquisition Corp. II (NASDAQ: ACAB) extended its business combination deadline by one month to November 19, 2023, after the Sponsor deposited $80,000 into its Trust Account.
Why It Matters
The extension of ACAB's business combination deadline indicates potential ongoing negotiations, impacting its valuation and investor confidence in future opportunities.
Source: PRNewsWire
Market Sentiment:
Neutral
Quick Summary
Abpro Corporation has announced a term sheet for a business combination with Atlantic Coastal Acquisition Corp. II, effective September 18, 2023.
Why It Matters
The merger between Abpro and Atlantic Coastal could lead to significant capital influx and growth potential in the biotech sector, impacting stock valuations and investor sentiment.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
Atlantic Coastal Acquisition Corp. II completed a $300 million IPO in January 2022.
Why It Matters
The $300 million IPO by Atlantic Coastal Acquisition Corp. II signals strong investor interest and capital availability, potentially affecting market trends and investment opportunities in SPACs.
Source: Seeking Alpha
Market Sentiment:
Neutral
Quick Summary
Atlantic Coastal Acquisition Corp. II will allow separate trading of its Series A common stock and warrants starting March 7, 2022. No fractional warrants will be issued.
Why It Matters
The separation of shares and warrants allows for increased trading flexibility and may enhance liquidity, potentially affecting stock valuations and investor strategies.
Source: PRNewsWire
Market Sentiment:
Neutral
Frequently Asked Questions About ACAB Stock
What is Abpro Holdings Inc.'s (ACAB) stock forecast for 2025?
Analyst forecasts for Abpro Holdings Inc. (ACAB) are not currently available. The stock is trading at $0.33.
Is ACAB stock a good investment in 2025?
Analyst ratings for ACAB are not currently available. The stock is currently trading at $0.33. Investment decisions should be based on thorough research and your personal financial goals. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for ACAB stock?
Price predictions from Wall Street analysts for ACAB are not currently available. The stock is trading at $0.33.
What is Abpro Holdings Inc.'s business model?
Abpro Holdings Inc. generates revenue by leveraging its proprietary antibody discovery platform to develop advanced therapies, particularly in oncology and ophthalmology. The company partners with other organizations to enhance research and development efforts, thus contributing to the biopharmaceutical industry.
What is the highest forecasted price for ACAB Abpro Holdings Inc.?
Price targets from Wall Street analysts for ACAB are not currently available. The stock is trading at $0.33.
What is the lowest forecasted price for ACAB Abpro Holdings Inc.?
Price targets from Wall Street analysts for ACAB are not currently available. The stock is trading at $0.33.
What is the overall ACAB consensus from analysts for Abpro Holdings Inc.?
Analyst ratings for ACAB are not currently available. The stock is trading at $0.33.
How accurate are ACAB stock price projections?
Stock price projections, including those for Abpro Holdings Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: April 28, 2025 9:07 AM UTC